The use of human serum samples to study malignant transformation: a pilot study

Obesity and excess adiposity account for approximately 20% of all cancer cases; however, biomarkers of risk remain to be elucidated. While fibroblast growth factor-2 (FGF2) is emerging as an attractive candidate biomarker for visceral adipose tissue mass, the role of circulating FGF2 in malignant tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Holowatyj, Andreana N. (VerfasserIn) , Gigić, Biljana (VerfasserIn) , Warby, Christy A. (VerfasserIn) , Ose, Jennifer (VerfasserIn) , Lin, Tengda (VerfasserIn) , Schrotz-King, Petra (VerfasserIn) , Ulrich, Cornelia (VerfasserIn) , Bernard, Jamie J. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 October 2021
In: Cells
Year: 2021, Jahrgang: 10, Heft: 10, Pages: 1-6
ISSN:2073-4409
DOI:10.3390/cells10102670
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cells10102670
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2073-4409/10/10/2670
Volltext
Verfasserangaben:Andreana N. Holowatyj, Biljana Gigic, Christy A. Warby, Jennifer Ose, Tengda Lin, Petra Schrotz-King, Cornelia M. Ulrich and Jamie J. Bernard

MARC

LEADER 00000caa a2200000 c 4500
001 1788858107
003 DE-627
005 20220820124058.0
007 cr uuu---uuuuu
008 220208s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/cells10102670  |2 doi 
035 |a (DE-627)1788858107 
035 |a (DE-599)KXP1788858107 
035 |a (OCoLC)1341441528 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Holowatyj, Andreana N.  |e VerfasserIn  |0 (DE-588)1209304120  |0 (DE-627)1696957117  |4 aut 
245 1 4 |a The use of human serum samples to study malignant transformation  |b a pilot study  |c Andreana N. Holowatyj, Biljana Gigic, Christy A. Warby, Jennifer Ose, Tengda Lin, Petra Schrotz-King, Cornelia M. Ulrich and Jamie J. Bernard 
264 1 |c 6 October 2021 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.02.2022 
520 |a Obesity and excess adiposity account for approximately 20% of all cancer cases; however, biomarkers of risk remain to be elucidated. While fibroblast growth factor-2 (FGF2) is emerging as an attractive candidate biomarker for visceral adipose tissue mass, the role of circulating FGF2 in malignant transformation remains unknown. Moreover, functional assays for biomarker discovery are limited. We sought to determine if human serum could stimulate the 3D growth of a non-tumorigenic cell line. This type of anchorage-independent 3D growth in soft agar is a surrogate marker for acquired tumorigenicity of cell lines. We found that human serum from cancer-free men and women has the potential to stimulate growth in soft agar of non-tumorigenic epithelial JB6 P+ cells. We examined circulating levels of FGF2 in humans in malignant transformation in vitro in a pilot study of n = 33 men and women. Serum FGF2 levels were not associated with colony formation in epithelial cells (r = 0.05, p = 0.80); however, a fibroblast growth factor receptor-1 (FGFR1) selective inhibitor significantly blocked serum-stimulated transformation, suggesting that FGF2 activation of FGFR1 may be necessary, but not sufficient for the transforming effects of human serum. This pilot study indicates that the FGF2/FGFR1 axis plays a role in JB6 P+ malignant transformation and describes an assay to determine critical serum factors that have the potential to promote tumorigenesis. 
650 4 |a body fatness 
650 4 |a body mass index 
650 4 |a FGF2 
650 4 |a obesity 
650 4 |a overweight 
700 1 |a Gigić, Biljana  |d 1978-  |e VerfasserIn  |0 (DE-588)1124096310  |0 (DE-627)877817561  |0 (DE-576)482295201  |4 aut 
700 1 |a Warby, Christy A.  |e VerfasserIn  |4 aut 
700 1 |a Ose, Jennifer  |d 1979-  |e VerfasserIn  |0 (DE-588)1136678018  |0 (DE-627)893435805  |0 (DE-576)490759270  |4 aut 
700 1 |a Lin, Tengda  |e VerfasserIn  |4 aut 
700 1 |a Schrotz-King, Petra  |e VerfasserIn  |0 (DE-588)1078258066  |0 (DE-627)838209327  |0 (DE-576)450367118  |4 aut 
700 1 |a Ulrich, Cornelia  |d 1967-  |e VerfasserIn  |0 (DE-588)1045797030  |0 (DE-627)775130133  |0 (DE-576)399253289  |4 aut 
700 1 |a Bernard, Jamie J.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cells  |d Basel : MDPI, 2012  |g 10(2021), 10, Artikel-ID 2670, Seite 1-6  |h Online-Ressource  |w (DE-627)718622081  |w (DE-600)2661518-6  |w (DE-576)365412112  |x 2073-4409  |7 nnas  |a The use of human serum samples to study malignant transformation a pilot study 
773 1 8 |g volume:10  |g year:2021  |g number:10  |g elocationid:2670  |g pages:1-6  |g extent:6  |a The use of human serum samples to study malignant transformation a pilot study 
856 4 0 |u https://doi.org/10.3390/cells10102670  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2073-4409/10/10/2670  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220208 
993 |a Article 
994 |a 2021 
998 |g 1045797030  |a Ulrich, Cornelia  |m 1045797030:Ulrich, Cornelia  |d 50000  |e 50000PU1045797030  |k 0/50000/  |p 7 
998 |g 1124096310  |a Gigić, Biljana  |m 1124096310:Gigić, Biljana  |d 910000  |d 910200  |e 910000PG1124096310  |e 910200PG1124096310  |k 0/910000/  |k 1/910000/910200/  |p 2 
999 |a KXP-PPN1788858107  |e 4053180341 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Andreana N. Holowatyj, Biljana Gigic, Christy A. Warby, Jennifer Ose, Tengda Lin, Petra Schrotz-King, Cornelia M. Ulrich and Jamie J. Bernard"]},"note":["Gesehen am 08.02.2022"],"physDesc":[{"extent":"6 S."}],"language":["eng"],"title":[{"title_sort":"use of human serum samples to study malignant transformation","title":"The use of human serum samples to study malignant transformation","subtitle":"a pilot study"}],"id":{"doi":["10.3390/cells10102670"],"eki":["1788858107"]},"recId":"1788858107","origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"6 October 2021"}],"relHost":[{"note":["Gesehen am 09.05.12"],"title":[{"title_sort":"Cells","subtitle":"open access journal","title":"Cells"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisherPlace":"Basel","publisher":"MDPI"}],"id":{"eki":["718622081"],"zdb":["2661518-6"],"issn":["2073-4409"]},"part":{"text":"10(2021), 10, Artikel-ID 2670, Seite 1-6","year":"2021","extent":"6","issue":"10","pages":"1-6","volume":"10"},"disp":"The use of human serum samples to study malignant transformation a pilot studyCells","pubHistory":["1.2012 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"718622081"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","display":"Holowatyj, Andreana N.","family":"Holowatyj","given":"Andreana N."},{"display":"Gigić, Biljana","family":"Gigić","role":"aut","given":"Biljana"},{"family":"Warby","display":"Warby, Christy A.","role":"aut","given":"Christy A."},{"given":"Jennifer","family":"Ose","display":"Ose, Jennifer","role":"aut"},{"role":"aut","display":"Lin, Tengda","family":"Lin","given":"Tengda"},{"given":"Petra","family":"Schrotz-King","display":"Schrotz-King, Petra","role":"aut"},{"given":"Cornelia","display":"Ulrich, Cornelia","family":"Ulrich","role":"aut"},{"display":"Bernard, Jamie J.","family":"Bernard","role":"aut","given":"Jamie J."}]} 
SRT |a HOLOWATYJAUSEOFHUMAN6202